Zoekresultaten - 3 results
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
lung-transplanted (28.6; 95% CI: 22.7-35.5) non-lung-transplanted pwCF (16.6; 95% CI: 15.4-17.8) (p≤0.001). SARS-CoV-2 infection caused symptomatic illness in 75.7%. Factors associated with symptomatic SARS-CoV-2 ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
a facilitating factor for ABPA. ABPA causes a significant increase in bronchial damage. In patients with ABPA, further bronchial damage can be controlled by an increase in hospitalization days and use of IV ...
The burden of cystic fibrosis in Belgium: a registry-based study
Disability-Adjusted Life Years Mucoviscidosis Abstract: Background: Cystic fibrosis is the most common life-limiting autosomal recessive disease among people of European heritage. This rare disease is known to cause ...